Relay Therapeutics's three largest insider shareholders as of April 17, 2026 are Mark Murcko (Director, 996.95K shares), Sanjiv Patel (President And Ceo, 661.04K shares), Donald A Bergstrom (President, Rd, 420.05K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Mark Murcko | - | 996,952 | 0 | 08 Sep, 2022 |
| Sanjiv Patel | President And Ceo | 661,041 | 0 | 07 Jan, 2026 |
| Donald A Bergstrom | President, Rd | 420,047 | 0 | 29 Jan, 2026 |
| Brian Adams | Chief Legal Officer | 371,472 | 0 | 30 Jul, 2025 |
| Peter Rahmer | - | 276,610 | 0 | 29 Jan, 2026 |
| Thomas Catinazzo | Chief Financial Officer | 213,867 | 0 | 09 Apr, 2026 |
| Sanjiv Patel | President And Ceo | 0 | 199,548 | 23 Jan, 2025 |
| Jami Rubin | - | 67,242 | 0 | 12 Jun, 2024 |
| Jami Rubin | - | 67,242 | 0 | 12 Jun, 2024 |
| Andy Porter | Chief Administrative Officer | 45,164 | 0 | 01 Nov, 2022 |
| Laura Shawver | - | 40,000 | 0 | 26 May, 2023 |
| Laura Shawver | - | 40,000 | 0 | 26 May, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Apr, 2026 | Thomas Catinazzo | Common Stock | D | 17,717 | $13.01 | 213,867 | D | S |
| 09 Apr, 2026 | Thomas Catinazzo | Common Stock | A | 1,800 | $5.22 | 215,667 | D | M |
| 09 Apr, 2026 | Thomas Catinazzo | Common Stock | D | 1,800 | $15.00 | 213,867 | D | S |
| 09 Apr, 2026 | Thomas Catinazzo | Stock Option (Right to Buy) | D | 1,800 | $0.00 | 61,563 | D | M |
| 09 Mar, 2026 | Thomas Catinazzo | Common Stock | D | 17,717 | $10.06 | 231,584 | D | S |
| 31 Dec, 2025 | Peter Rahmer | Common Stock | A | 994 | $2.99 | 338,463 | D | A |
| 27 Jan, 2026 | Thomas Catinazzo | Common Stock | D | 13,820 | $7.62 | 250,996 | D | S |
| 27 Jan, 2026 | Donald A Bergstrom | Common Stock | D | 18,895 | $7.62 | 422,733 | D | S |
| 27 Jan, 2026 | Peter Rahmer | Common Stock | D | 11,684 | $7.62 | 277,964 | D | S |
| 28 Jan, 2026 | Thomas Catinazzo | Common Stock | D | 1,695 | $8.45 | 249,301 | D | S |
| 28 Jan, 2026 | Donald A Bergstrom | Common Stock | D | 2,686 | $8.45 | 420,047 | D | S |
| 28 Jan, 2026 | Peter Rahmer | Common Stock | D | 1,354 | $8.45 | 276,610 | D | S |
| 13 Jan, 2026 | Donald A Bergstrom | Stock Option (Right to Buy) | A | 575,000 | $0.00 | 575,000 | D | A |
| 13 Jan, 2026 | Peter Rahmer | Stock Option (Right to Buy) | A | 475,000 | $0.00 | 475,000 | D | A |
| 13 Jan, 2026 | Thomas Catinazzo | Stock Option (Right to Buy) | A | 400,000 | $0.00 | 400,000 | D | A |
| 13 Jan, 2026 | Sanjiv Patel | Stock Option (Right to Buy) | A | 1,450,000 | $0.00 | 1,450,000 | D | A |
| 31 Dec, 2025 | Sanjiv Patel | Common Stock | A | 994 | $2.99 | 704,209 | D | A |
| 06 Jan, 2026 | Sanjiv Patel | Common Stock | D | 43,168 | $7.82 | 661,041 | D | S |
| 04 Nov, 2025 | Habib J Dable | Stock Option (Right to Buy) | A | 207,931 | $0.00 | 207,931 | D | A |
| 04 Nov, 2025 | Lonnel Coats | Stock Option (Right to Buy) | A | 207,931 | $0.00 | 207,931 | D | A |